Pediatric Rheumatology

You have full text access to this OnlineOpen article

Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis

  1. H. M. Albers1,
  2. J. A. M. Wessels1,
  3. R. J. H. M. van der Straaten1,
  4. D. M. C. Brinkman1,
  5. L. W. A. Suijlekom-Smit2,
  6. S. S. M. Kamphuis2,
  7. H. J. Girschick3,
  8. C. Wouters4,
  9. M. W. Schilham1,
  10. S. le Cessie1,
  11. T. W. J. Huizinga1,
  12. R. ten Cate1,*,
  13. H. J. Guchelaar1,†

Article first published online: 30 DEC 2008

DOI: 10.1002/art.24087

Issue

Arthritis Care & Research

Arthritis Care & Research

Volume 61, Issue 1, pages 46–51, 15 January 2009

Additional Information

How to Cite

Albers, H. M., Wessels, J. A. M., van der Straaten, R. J. H. M., Brinkman, D. M. C., Suijlekom-Smit, L. W. A., Kamphuis, S. S. M., Girschick, H. J., Wouters, C., Schilham, M. W., le Cessie, S., Huizinga, T. W. J., ten Cate, R. and Guchelaar, H. J. (2009), Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis. Arthritis & Rheumatism, 61: 46–51. doi: 10.1002/art.24087

Author Information

  1. 1

    Leiden University Medical Center, Leiden, The Netherlands

  2. 2

    Erasmus MC Sophia Children's Hospital, Rotterdam, The Netherlands

  3. 3

    University of Wurzburg, Wurzburg, Germany

  4. 4

    Gasthuisberg University Hospital, Leuven, Belgium

  1. †

    Dr. Guchelaar holds a patent for methotrexate pharmacogenetics.

*Department of Pediatrics, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, The Netherlands

Publication History

  1. Issue published online: 30 DEC 2008
  2. Article first published online: 30 DEC 2008
  3. Manuscript Accepted: 11 SEP 2008
  4. Manuscript Received: 13 MAY 2008

Funded by

  • Dutch Arthritis Association. Grant Numbers: NR-05-1-403, KFS-04-2-202

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (75K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    K. Minden, M. Niewerth, A. Zink, E. Seipelt, I. Foeldvari, H. Girschick, G. Ganser, G. Horneff, Long-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBO, Rheumatology, 2012,

    CrossRef

  2. 2
    S. C. Li, Earlier Methotrexate Treatment Important for Juvenile Arthritis, AAP Grand Rounds, 2009, 21, 6, 67

    CrossRef

  3. 3
    H. Foster, T. Rapley, C. May, Juvenile idiopathic arthritis: improved outcome requires improved access to care, Rheumatology, 2009, 49, 3, 401

    CrossRef

View Full Article (HTML) Get PDF (75K)